Kumar Rakhi
CIK 0001856296
Chief Accounting OfficerDirector
Filings
53
Latest Mar 23, 2026
Issuers covered
2
Showing
50 of 53
Page 1
Track record
21 of 21 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 21 | 52% | +3.5% | +2.4% | +26.2% | -15.4% |
| 90 days | 21 | 52% | +0.9% | +0.8% | +31.8% | -45.9% |
| 180 days | 21 | 71% | +3.9% | +2.3% | +39.0% | -52.1% |
| 365 days | 21 | 24% | -43.5% | -30.2% | +9.1% | -161.1% |
Issuers
Companies where Kumar Rakhi has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | 45 | Feb 24, 2025 |
| NPCE | Neuropace Inc | 8 | Mar 23, 2026 |
All filings
53 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|